Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function

G Mathe - Biomedicine & pharmacotherapy, 1991 - Elsevier
G Mathe
Biomedicine & pharmacotherapy, 1991Elsevier
Abstract Bestatin, the dipeptide N-[(2S, 3R)-3-amino-2-hydroxy-4-phenyl butanyl) l-leucine is
a leucine aminopeptidase and aminopeptidase-B inhibitor. It exerts a direct stimulating effect
on lymphocytes (and monocytes) via its fixation on cell surface leucinc-aminopeptidase, and
an indirect effect on monocytes (and lymphocytes) via aminopeptidase B inhibition of tuftsin
catabolism. Thus it is an immuno-modifier as shown by the Japanese and also our groups:
a) immunomodifier, especially slimulator, in normal young mice; b) immunorestorator and …
Abstract
Bestatin, the dipeptide N-[(2S, 3R)-3-amino-2-hydroxy-4-phenyl butanyl) l-leucine is a leucine aminopeptidase and aminopeptidase-B inhibitor. It exerts a direct stimulating effect on lymphocytes (and monocytes) via its fixation on cell surface leucinc-aminopeptidase, and an indirect effect on monocytes (and lymphocytes) via aminopeptidase B inhibition of tuftsin catabolism. Thus it is an immuno-modifier as shown by the Japanese and also our groups: a) immunomodifier, especially slimulator, in normal young mice; b) immunorestorator and spontaneous tumor preventive agent in aged mice: c) immunorestorator in the elderly and in cancer patients and HIV infected subjects. It stimulates granulocytopoiesis and thrombocytopoiesis in vitro, and can restore them in vivo in myelo-hypoplastic man. The anti-aminopeptidase action of Bestatin also protects enkephalins againt their catabolism, which encouraged us, with good preliminary results, to study its analgesic action and search for a preventive effect on “desaddicted” toxicomaniac relapses.
Bestatin/anti-aminopeptidase/pharmacological action
Elsevier